Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study on Predictors of Early On-treatment Response and Sustained Virological Response in a Cohort of Treatment naïve HCV-infected Patients Treated With Pegylated Interferons

NCT01066819 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01066819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01066819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study on Predictors of Early On-treatment Response and Sustained Virological Response in a Cohort of Treatment naïve HCV-infected Patients Treated With Pegylated Interferons
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
January 31, 2008
Completion date
August 31, 2011
Enrollment
1,656 (actual)
Sites
106

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, chronic